The dose-response of norepinephrine in preventing hypotension induced by spinal anesthesia and oxytocin in cesarean section

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014614

Enrollment

Unknown

Registered

2018-01-24

Start date

2018-02-01

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

1:0.02ug/kg/min norepinephrine

2:0.03ug/kg/min norepinephrine

3:0.04ug/kg/min norepinephrine

4:0.05ug/kg/min norepinephrine

5:0.06ug/kg/min norepinephrine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria healthy patients with ASA status ? or ??, who required to have an elective cesarean section, were enrolled in this study.

Exclusion criteria

Exclusion criteria: Exclusion criteria as follows: patients with a body mass index (BMI) > 35 kg/m2; any complication to local anesthesia, including coagulopathy and local or general infection; obstetrics issues such as pre-eclampsia, ruptured membranes, gestational age less than 37 weeks, cesarean section history, early or active labor, intrauterine growth restriction; coexisting disease including diabetes or hypertension.

Design outcomes

Primary

Measure	Time frame
blood pressure;	—

Secondary

Measure	Time frame
side effects;	—

Contacts

Public ContactXiao Fei

Jiaxing University Affiliated Women and Children Hospital, Jiaxing Maternity and Child Care Hospital

13706597501@163.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026